Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Brain Research|August 18, 2010
Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluidAudrey Gabelle, Stéphane Roche, Christian Gény, et al.
Journal of Alzheimer'S Disease : JAD|June 29, 2011
Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementiaAudrey Gabelle, Stéphane Roche, Christian Gény, et al.
European Journal of Neurology|April 16, 2026
Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic AmyotrophyJulian Theuriet, Isabelle Quadrio, Frédéric Fer, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2012
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubesArmand Perret-Liaudet, Mathieu Pelpel, Yannick Tholance, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort StudyIker Elosua-Bayes, Pauline Dumez, Marie Benaiteau, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 26, 2013
Impact of harmonization of collection tubes on Alzheimer's disease diagnosisSylvain Lehmann, Susanna Schraen, Isabelle Quadrio, et al.
Alzheimer'S Research & Therapy|May 7, 2025
Soluble SorLA in CSF, a novel biomarker to explore disrupted trafficking of SorLA protein in Alzheimer diseaseRomain Castelot, Aline Zarea, David Wallon, et al.
Frontiers in Neurology|July 21, 2017
Multicenter Analytical Validation of Aβ40 ImmunoassaysLinda J C van Waalwijk van Doorn, Luka Kulic, Marleen J A Koel-Simmelink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overviewConstance Delaby, Aurélie Ladang, Jose Martinez-Yriarte, et al.
Pageof 8